Status:
ACTIVE_NOT_RECRUITING
Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Kawasaki Disease
Eligibility:
All Genders
1-17 years
Phase:
EARLY_PHASE1
Brief Summary
Kawasaki disease (KD) is the leading cause of acquired heart disease in children in the developed world. Despite available treatment, 25% of children in San Diego County appropriately treated for KD d...
Eligibility Criteria
Inclusion
- Acute Kawasaki disease with a Z score of 3 or larger of the LAD or RCA
Exclusion
- Taking a CYP3A4 metabolized drug (such as cyclosporine)
Key Trial Info
Start Date :
October 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04747847
Start Date
October 9 2017
End Date
April 1 2025
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Diego
San Diego, California, United States, 92093